Literature DB >> 21274425

Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Pavan K Battiprolu1, Thomas G Gillette, Zhao V Wang, Sergio Lavandero, Joseph A Hill.   

Abstract

The incidence and prevalence of diabetes mellitus are each increasing rapidly in our society. The majority of patients with diabetes succumb ultimately to heart disease, much of which stems from atherosclerotic disease and hypertension. However, cardiomyopathy can develop independent of elevated blood pressure or coronary artery disease, a process termed diabetic cardiomyopathy. This disorder is a complex diabetes-associated process characterized by significant changes in the physiology, structure, and mechanical function of the heart. Here, we review recently derived insights into mechanisms and molecular events involved in the pathogenesis of diabetic cardiomyopathy.

Entities:  

Year:  2010        PMID: 21274425      PMCID: PMC3026473          DOI: 10.1016/j.ddmec.2010.08.001

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  85 in total

Review 1.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

2.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

3.  Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.

Authors:  Darrell D Belke; Eric A Swanson; Wolfgang H Dillmann
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 4.  Insulin signaling in heart muscle: lessons from genetically engineered mouse models.

Authors:  E Dale Abel
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

5.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

6.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

7.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

9.  Role of resistin in cardiac contractility and hypertrophy.

Authors:  Maengjo Kim; Jae Kyun Oh; Susumu Sakata; Iifan Liang; Woojin Park; Roger J Hajjar; Djamel Lebeche
Journal:  J Mol Cell Cardiol       Date:  2008-05-20       Impact factor: 5.000

10.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

View more
  57 in total

1.  Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats.

Authors:  Sanda Despa; Kenneth B Margulies; Le Chen; Anne A Knowlton; Peter J Havel; Heinrich Taegtmeyer; Donald M Bers; Florin Despa
Journal:  Circ Res       Date:  2012-01-24       Impact factor: 17.367

Review 2.  Muscle as a "mediator" of systemic metabolism.

Authors:  Kedryn K Baskin; Benjamin R Winders; Eric N Olson
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

3.  Adipocyte-specific loss of PPARγ attenuates cardiac hypertrophy.

Authors:  Xi Fang; Matthew J Stroud; Kunfu Ouyang; Li Fang; Jianlin Zhang; Nancy D Dalton; Yusu Gu; Tongbin Wu; Kirk L Peterson; Hsien-Da Huang; Ju Chen; Nanping Wang
Journal:  JCI Insight       Date:  2016-10-06

4.  Molecular Basis of Insulin Resistance: The Role of IRS and Foxo1 in the Control of Diabetes Mellitus and Its Complications.

Authors:  Shaodong Guo
Journal:  Drug Discov Today Dis Mech       Date:  2013-06-01

Review 5.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

6.  Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015.

Authors:  Yiling J Cheng; Giuseppina Imperatore; Linda S Geiss; Sharon H Saydah; Ann L Albright; Mohammed K Ali; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-08-21       Impact factor: 19.112

Review 7.  Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.

Authors:  Francisco Westermeier; Mario Navarro-Marquez; Camila López-Crisosto; Roberto Bravo-Sagua; Clara Quiroga; Mario Bustamante; Hugo E Verdejo; Ricardo Zalaquett; Mauricio Ibacache; Valentina Parra; Pablo F Castro; Beverly A Rothermel; Joseph A Hill; Sergio Lavandero
Journal:  Biochim Biophys Acta       Date:  2015-02-14

8.  Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts.

Authors:  Tae Hee Ko; Jubert C Marquez; Hyoung Kyu Kim; Seung Hun Jeong; SungRyul Lee; Jae Boum Youm; In Sung Song; Dae Yun Seo; Hye Jin Kim; Du Nam Won; Kyoung Im Cho; Mun Gi Choi; Byoung Doo Rhee; Kyung Soo Ko; Nari Kim; Jong Chul Won; Jin Han
Journal:  Pflugers Arch       Date:  2017-10-14       Impact factor: 3.657

Review 9.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

10.  Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.

Authors:  Caronda J Moore; Chun Hong Shao; Ryoji Nagai; Shelby Kutty; Jaipaul Singh; Keshore R Bidasee
Journal:  Mol Cell Biochem       Date:  2013-01-25       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.